Peter Thuss-Patience
彼得·图斯-佩顿斯
MD, PhD
Professor of Medical Oncology, Head of GI Oncology肿瘤内科教授，胃肠肿瘤科主任
👥Biography 个人简介
Key European leader in gastric and esophageal cancer. Contributed to FLOT neoadjuvant regimen development and ToGA trial establishing trastuzumab in HER2+ gastric cancer. Active in perioperative chemotherapy optimization and biomarker-driven patient selection in Germany and across Europe.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Perioperative Chemotherapy
Contributed to FLOT4-AIO trial validating FLOT as perioperative standard over ECF/ECX for resectable gastric and GEJ adenocarcinoma in Europe.
HER2+ Gastric Cancer
Participated in ToGA trial that established trastuzumab with chemotherapy as standard first-line treatment for HER2-overexpressing advanced gastric cancer.
Representative Works 代表性著作
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin (FLOT4)
The Lancet (2019)
Established FLOT as new perioperative standard for resectable gastric/GEJ adenocarcinoma.
Trastuzumab plus chemotherapy for HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA)
The Lancet (2010)
Defined HER2 as first actionable target in gastric cancer, practice-changing globally.
🏆Awards & Recognition 奖项与荣誉
📄Data Sources 数据来源
Last updated: 2026-01-15 | All information from publicly available academic sources
Related Experts 相关专家
Hope S. Rugo
University of California, San Francisco (UCSF)
Maryam B. Lustberg
Yale School of Medicine / Yale Cancer Center
Sara M. Tolaney
Dana-Farber Cancer Institute / Harvard Medical School
Carlos H. Barrios
PUCRS (Pontifical Catholic University of Rio Grande do Sul) / Hospital São Lucas, Porto Alegre, Brazil
关注 彼得·图斯-佩顿斯 的研究动态
Follow Peter Thuss-Patience's research updates
留下邮箱，当我们发布与 Peter Thuss-Patience（Charité – Universitätsmedizin Berlin）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment